Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2015

01-12-2015 | Endocrine Tumors

Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades

Authors: Margaret Livingstone, MD, Kaylene Duttchen, MD, FRCPC, Jenny Thompson, MD, Zahid Sunderani, MD, Geoffrey Hawboldt, MD, FRCPC, M. Sarah Rose, PhD, Janice Pasieka, MD, FRCSC, FACS

Published in: Annals of Surgical Oncology | Issue 13/2015

Login to get access

Abstract

Background

Ideal perioperative management of pheochromocytomas/paragangliomas (pheo) is a subject of debate and can be highly variable. The purpose of this study was to identify potential predictive factors of hemodynamic instability during pheo resection.

Methods

A retrospective review of pheo resections from 1992 to 2013 was undertaken. Intraoperative hemodynamics, patient demographics, tumor characteristics, and perioperative management were examined. Postoperative intensive-care admission, myocardial infarction, stroke, and 30-day mortality were reviewed. Linear regression was used to analyze factors influencing intraoperative hemodynamics.

Results

During the 20-year study period, 100 patients underwent pheo resection. Postoperative morbidity and mortality was significantly reduced (p = 0.003) in the last 10 years of practice, and there was a trend towards greater morbidity and mortality with intraoperative hemodynamic instability (p = 0.06). The preoperative dose of phenoxybenzamine and the number of laparoscopic procedures has increased in the last decade [59 mg (95 % CI 32–108) to 106 mg (95 % CI 91–124), p = 0.008, and 27 vs. 54 %, p = 0.05, respectively]. Increased preoperative phenoxybenzamine dose was a significant predictor of improved intraoperative hemodynamic stability (p = 0.01). Lack of intraoperative magnesium use resulted in greater hemodynamic instability as preoperative systolic blood pressure increased (p = 0.002).

Conclusions

Postoperative outcomes following pheo resection have improved over the last two decades. Preoperative α-blockade plays a significant role in improving intraoperative hemodynamics and post-op outcomes. Increased doses of phenoxybenzamine and utilization of laparoscopic approaches have likely contributed to improved outcomes in the last decade. Intraoperative magnesium use may provide protection against hemodynamic instability and warrants further study.
Literature
1.
go back to reference Hull C. Pheochromocytoma: diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth. 1986;58:1453–68.CrossRefPubMed Hull C. Pheochromocytoma: diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth. 1986;58:1453–68.CrossRefPubMed
2.
go back to reference Kinney M, Warner M, vanHeerden J, Horlocker T, Young W, Schroeder D, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91:1118–23.PubMed Kinney M, Warner M, vanHeerden J, Horlocker T, Young W, Schroeder D, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91:1118–23.PubMed
3.
go back to reference Apgar V, Papper EM. Pheochromocytoma: anesthetic management during surgical treatment. Arch Surg. 1951;62:634–48.CrossRef Apgar V, Papper EM. Pheochromocytoma: anesthetic management during surgical treatment. Arch Surg. 1951;62:634–48.CrossRef
4.
go back to reference Desmonts JM, le Houelleur J, Remond P, Duvaldestin P. Anaesthetic management of patients with pheochromocytoma: a review of 102 cases. Br J Anaesth. 1977;49:991–7.CrossRefPubMed Desmonts JM, le Houelleur J, Remond P, Duvaldestin P. Anaesthetic management of patients with pheochromocytoma: a review of 102 cases. Br J Anaesth. 1977;49:991–7.CrossRefPubMed
5.
go back to reference Van Heerden HA, Roland CF, Carney JA, et al. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg. 1990;14:325–9.CrossRefPubMed Van Heerden HA, Roland CF, Carney JA, et al. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg. 1990;14:325–9.CrossRefPubMed
6.
go back to reference Warner MA, vanHeerden JA. Anesthetic and surgical management at the May Clinic. In: Manager WM, Gifford RW (eds). Clinical and experimental pheochromocytoma. 2nd ed. Cambridge: Blackwell Science;1996; 388–407. Warner MA, vanHeerden JA. Anesthetic and surgical management at the May Clinic. In: Manager WM, Gifford RW (eds). Clinical and experimental pheochromocytoma. 2nd ed. Cambridge: Blackwell Science;1996; 388–407.
7.
go back to reference Pacak K, Eisenhofer G, Ahlman H et al. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Endocrinol Metab. 2007; 3:92–102.CrossRefPubMed Pacak K, Eisenhofer G, Ahlman H et al. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Endocrinol Metab. 2007; 3:92–102.CrossRefPubMed
8.
go back to reference Wellbourn RB. Early surgical history of phaeochromocytoma. Br J Surg. 1987;74:594–6.CrossRef Wellbourn RB. Early surgical history of phaeochromocytoma. Br J Surg. 1987;74:594–6.CrossRef
9.
go back to reference Boutros A, Bravo E, Zenettin G, et al. Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med. 1990;57:613–617.CrossRefPubMed Boutros A, Bravo E, Zenettin G, et al. Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med. 1990;57:613–617.CrossRefPubMed
10.
go back to reference Steinsapir J, Carr A, Prisant M, et al. Metyrosin and pheochromocytoma. Arch Intern Med. 1997;157:901–6.CrossRefPubMed Steinsapir J, Carr A, Prisant M, et al. Metyrosin and pheochromocytoma. Arch Intern Med. 1997;157:901–6.CrossRefPubMed
11.
go back to reference Horst-Schrivers A, Kerstens M, Wolffenbuttel B. Preoperative pharmacological management of phaeochromocytoma. Neth J Med. 2006;64(8):290–5.PubMed Horst-Schrivers A, Kerstens M, Wolffenbuttel B. Preoperative pharmacological management of phaeochromocytoma. Neth J Med. 2006;64(8):290–5.PubMed
12.
go back to reference Agrawal R, Mishra S, Bhatia E, et al. Prospective study to compare the perioperative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38:716–23.CrossRefPubMed Agrawal R, Mishra S, Bhatia E, et al. Prospective study to compare the perioperative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38:716–23.CrossRefPubMed
13.
go back to reference Bruynzeel H, Feelders A, Groenland T, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endorcinol Metab. 2010;95:678–85.CrossRef Bruynzeel H, Feelders A, Groenland T, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endorcinol Metab. 2010;95:678–85.CrossRef
14.
15.
go back to reference Kim H, Kim G, Sung G. Laparoscopic adrenalectomy for pheochromoctyoma: comparison with conventional open adrenalectomy. J Endourol. 2004;18:251–5.CrossRefPubMed Kim H, Kim G, Sung G. Laparoscopic adrenalectomy for pheochromoctyoma: comparison with conventional open adrenalectomy. J Endourol. 2004;18:251–5.CrossRefPubMed
16.
go back to reference Jankovic R, Konstantinovic S, Milic D, et al. Can a patient be successfully prepared for pheochromocytoma surgery in three days? A case report. Minerva Anestesiol. 2007;73:245–8.PubMed Jankovic R, Konstantinovic S, Milic D, et al. Can a patient be successfully prepared for pheochromocytoma surgery in three days? A case report. Minerva Anestesiol. 2007;73:245–8.PubMed
17.
go back to reference James M. Use of magnesium sulphate in the anaesthetic management of pheochromocytoma: a review of 17 anaesthetics. Br J Anaesth. 1989;62:616–23.CrossRefPubMed James M. Use of magnesium sulphate in the anaesthetic management of pheochromocytoma: a review of 17 anaesthetics. Br J Anaesth. 1989;62:616–23.CrossRefPubMed
18.
19.
go back to reference Evan G. Magnesium sulfate and epidural anesthesia in pheochromocytoma and severe coronary artery disease. Anesth Analg. 1995;81:414–6. Evan G. Magnesium sulfate and epidural anesthesia in pheochromocytoma and severe coronary artery disease. Anesth Analg. 1995;81:414–6.
20.
go back to reference Lord M, Augoustides J. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothor Vasc Anesth. 2012;26(3):526–31.CrossRef Lord M, Augoustides J. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothor Vasc Anesth. 2012;26(3):526–31.CrossRef
21.
go back to reference Cook R, McDonald J, Nunziata E. Differences between hand-written and automatic blood pressure records. Anesthesiology 1989;71:385–90.CrossRefPubMed Cook R, McDonald J, Nunziata E. Differences between hand-written and automatic blood pressure records. Anesthesiology 1989;71:385–90.CrossRefPubMed
Metadata
Title
Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades
Authors
Margaret Livingstone, MD
Kaylene Duttchen, MD, FRCPC
Jenny Thompson, MD
Zahid Sunderani, MD
Geoffrey Hawboldt, MD, FRCPC
M. Sarah Rose, PhD
Janice Pasieka, MD, FRCSC, FACS
Publication date
01-12-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 13/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4519-y

Other articles of this Issue 13/2015

Annals of Surgical Oncology 13/2015 Go to the issue